Recent advances in radiation therapy and hormone treatment are reshaping oncology, while patientcentered marketing strategies have become key to engaging patients in a more meaningful way. Together, these elements reflect a broader transformation in cancer care that extends beyond clinical innovation.

Several trends are driving this expansion: the integration of artificial intelligence in treatment planning advances in biomarkerdriven hormone therapies, and a growing emphasis on personalized communication strategies that align with patient preferences. These forces are shaping a more responsive and efficient cancer care ecosystem, positioning the industry for continued growth in the years ahead.

This edition of Healthcare Business Review brings recent developments in technologies, therapies and service models redefining oncology.

It features thought leadership articles from industry experts, including J. Krystal Ascencio, acting chairperson department obstetrics and gynecology at Jamaica Hospital, who explores the critical and often-overlooked link between pregnancy complications and long-term cardiovascular disease (CVD) risk in women. Madison Haberl R.T(R), director of Radiology at St. Anthony Regional Hospital, explores the overuse of medical imaging in healthcare and the urgent need for more responsible, patient-centered imaging practices.

We hope this edition helps you build the partnerships and strategies your organization needs to deliver high-value, patientfocused oncology care now and into the future.